CaMKII may regulate renal tubular epithelial cell apoptosis through YAP/NFAT2 in acute kidney injury mice

References

• Kashani K, Rosner MH, Haase M, et al. Quality improvement goals for acute kidney injury. Clin J Am Soc Nephrol. 2019;14(6):941–953.
   PubMed Web of Science ®Google Scholar
• Lunyera J, Clare RM, Chiswell K, et al. Racial differences in AKI incidence following percutaneous coronary intervention. J Am Soc Nephrol. 2021;32(3):654–662.
   PubMed Web of Science ®Google Scholar
• Che R, Quadri MM, Zhang A. The epidemiology and management of pediatric AKI in asia. Semin Nephrol. 2020;40(5):516–532.
   PubMed Web of Science ®Google Scholar
• Hu C, Zhou G, Liu K, et al. CaMKII as a key regulator of contrast-induced nephropathy through mPTP opening in HK-2 cells. Cell Signal. 2020;75:109734.
   PubMed Web of Science ®Google Scholar
• Bracken C, Beauverger P, Duclos O, et al. CaMKII as a pathological mediator of ER stress, oxidative stress, and mitochondrial dysfunction in a murine model of nephronophthisis. Am jo Physiol. Renal Physiol. 2016;310(11):F1414–1422.
   PubMed Web of Science ®Google Scholar
• Lim JR, Lee HJ, Jung YH, et al. Ethanol-activated CaMKII signaling induces neuronal apoptosis through Drp1-mediated excessive mitochondrial fission and JNK1-dependent NLRP3 inflammasome activation. Cell Commun Signal. 2020;18(1):123.
   PubMed Web of Science ®Google Scholar
• Zhang T, Zhang Y, Cui M, et al. CaMKII is a RIP3 substrate mediating ischemia- and oxidative stress-induced myocardial necroptosis. Nat Med. 2016;22(2):175–182.
   PubMed Web of Science ®Google Scholar
• Zhang L, Li R, Shi W, et al. NFAT2 inhibitor ameliorates diabetic nephropathy and podocyte injury in db/db mice. Br J Pharmacol. 2013;170(2):426–439.
   PubMed Web of Science ®Google Scholar
• Li R, Zhang L, Shi W, et al. NFAT2 mediates high glucose-induced glomerular podocyte apoptosis through increased Bax expression. Exp Cell Res. 2013;319(7):992–1000.
   PubMed Web of Science ®Google Scholar
• Sato K, Suematsu A, Nakashima T, et al. Regulation of osteoclast differentiation and function by the CaMK-CREB pathway. Nat Med. 2006;12(12):1410–1416.
   PubMed Web of Science ®Google Scholar
• Schwartzman M, Reginensi A, Wong JS, et al. Podocyte-specific deletion of yes-associated protein causes FSGS and progressive renal failure. J Am Soc Nephrol. 2016;27(1):216–226.
   PubMed Web of Science ®Google Scholar
• He L, Yuan L, Yu W, et al. A regulation loop between Yap and NR4A1 balances cell proliferation and apoptosis. Cell Rep. 2020;33(3):108284.
   PubMed Web of Science ®Google Scholar
• Cao X, Pfaff SL, Gage FH. Yap regulates neural progenitor cell number via the TEA domain transcription factor. Genes Dev. 2008;22(23):3320–3334.
   PubMed Web of Science ®Google Scholar
• Halder G, Dupont S, Piccolo S. Transduction of mechanical and cytoskeletal cues by Yap and TAZ. Nat Rev Mol Cell Biol. 2012;13(9):591–600.
   PubMed Web of Science ®Google Scholar
• Huang Z. Mechanism of podocyte apoptosis regulated by Cdc42/YAP/NFAT signal pathway. China National Knowledge Internet: nephrology, southern medical university 2016.
   Google Scholar
• Huang Z, Zhang L, Chen Y, et al. Cdc42 deficiency induces podocyte apoptosis by inhibiting the nwasp/stress fibers/Yap pathway. Cell Death Dis. 2016;7(3):e2142.
   PubMedGoogle Scholar
• Huang Z, Peng Y, Yu H, et al. RhoA protects the podocytes against high glucose-induced apoptosis through Yap and plays critical role in diabetic nephropathy. Biochem Biophys Res Commun. 2018;504(4):949–956.
   PubMed Web of Science ®Google Scholar
• Chen J, Harris RC. Interaction of the EGF receptor and the hippo pathway in the diabetic kidney. J Am Soc Nephrol. 2016;27(6):1689–1700.
   PubMed Web of Science ®Google Scholar
• Percie Du Sert N, Hurst V, Ahluwalia A, et al. The ARRIVE guidelines 2.0: updated guidelines for reporting animal research. J Physiol. 2020;598(18):3793–3801.
   PubMed Web of Science ®Google Scholar
• Marshall CB, Krofft RD, Pippin JW, et al. CDK inhibitor p21 is prosurvival in adriamycin-induced podocyte injury, in vitro and in vivo. Am J Physiol Renal Physiol. 2010;298(5):F1140–1151.
   PubMed Web of Science ®Google Scholar
• Sun L, Shen YL, Liu HJ, et al. The expression of response gene to complement 32 on renal ischemia reperfusion injury in rat. Ren Fail. 2016;38(2):276–281.
   PubMed Web of Science ®Google Scholar
• Nie J, Ta N, Liu L, et al. Activation of CaMKII via ER-stress mediates coxsackievirus B3-induced cardiomyocyte apoptosis. Cell Biol Int. 2020;44(2):488–498.
   PubMed Web of Science ®Google Scholar
• Sepúlveda M, Burgos JI, Ciocci Pardo A, et al. CaMKII-dependent ryanodine receptor phosphorylation mediates sepsis-induced cardiomyocyte apoptosis. J Cell Mol Med. 2020;24(17):9627–9637.
   PubMed Web of Science ®Google Scholar
• Yang L. Acute kidney injury in asia. Kidney Dis. 2016;2(3):95–102.
   Google Scholar
• Huang J, Xu D, Yang L. Acute kidney injury in asia: disease burden. Semin Nephrol. 2020;40(5):443–455.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Feng J, Wang Q, et al. Hyperglycaemia stress-induced renal injury is caused by extensive mitochondrial fragmentation, attenuated MKP1 signalling, and activated JNK-CaMKII-Fis1 biological axis. Cell Physiol Biochem. 2018;51(4):1778–1798.
   PubMedGoogle Scholar
• Wang Y, Liu Q, Cai J, et al. Emodin prevents renal ischemia-reperfusion injury via suppression of CAMKII/DRP1-mediated mitochondrial fission. Eur J Pharmacol. 2022;916:174603.
   PubMed Web of Science ®Google Scholar
• Zhang H, Liang S, Du Y, et al. Inducible ATF3-NFAT axis aggravates podocyte injury. J Mol Med. 2018;96(1):53–64.
   PubMed Web of Science ®Google Scholar
• Xie ZY, Dong W, Zhang L, et al. NFAT inhibitor 11R-VIVIT ameliorates mouse renal fibrosis after ischemia-reperfusion-induced acute kidney injury. Acta Pharmacol Sin. 2022;43(8):2081–2093.
   PubMed Web of Science ®Google Scholar
• An N, Chen Y, Xing Y, et al. Cardiac CaMKIIdelta and wenxin keli prevents ang II-Induced cardiomyocyte hypertrophy by modulating CnA-NFATc4 and inflammatory signaling pathways in H9c2 cells. Evid Based Complement Alternat Med. 2020;2020:9502651.
   PubMed Web of Science ®Google Scholar
• Nie J, Duan Q, He M, et al. Ranolazine prevents pressure overload-induced cardiac hypertrophy and heart failure by restoring aberrant Na(+) and Ca(2+) handling. J Cell Physiol. 2019;234(7):11587–11601.
   PubMed Web of Science ®Google Scholar